GlassScriptPhysician profile
Amanda S Roye
NPI 1891316212
$691.96
in general payments reported to CMS, 2019-2025
9 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $74.04 · 2024: $422 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $276.57 | 2024 | Watchman Access System |
| Edwards Lifesciences Corporation | $181.30 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amgen INC. | $65.55 | 2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $48.41 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.17 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.63 | 2022 | |
| Biosense Webster, INC. | $20.23 | 2025 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $15.39 | 2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $14.71 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Roye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.